Conference
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539
Abstract
BACKGROUND: Three- and five-year progression-free survival (PFS) for low-risk meningioma managed with surgery and observation reportedly exceeds 90%. Herewith we summarize outcomes for low-risk meningioma patients enrolled on NRG/RTOG 0539.
METHODS: This phase II trial allocated patients to one of three groups per World Health Organization grade, recurrence status, and resection extent. Low-risk patients had either gross total (GTR) or subtotal …
Authors
Rogers CL; Pugh SL; Vogelbaum MA; Perry A; Ashby LS; Modi JM; Alleman AM; Barani IJ; Braunstein S; Bovi JA
Volume
25
Pagination
pp. 137-145
Publisher
Oxford University Press (OUP)
Publication Date
January 5, 2023
DOI
10.1093/neuonc/noac137
Conference proceedings
Neuro-Oncology
Issue
1
ISSN
1522-8517